TMO:TSX, Thermo Fisher CDR (CAD Hedged)
TMO stock overview
Thermo Fisher CDR (CAD Hedged) (TMO:TSX) closed at $23.95 on October 23, 2026,
down 0.50% on the day.
The stock trades 4.5% below its 52-week high of $25.09
and 52.2% above its 52-week low of $15.74.
Over the past year, it gained 14.5%.
Thermo Fisher CDR (CAD Hedged) is part of the Miscellaneous sector.
Key figures
- Price
- $23.95
- Day change
- -0.50%
- Volume
- 1,536
- Average volume
- 13,600
- Market cap
- 325B+
- 52-week range
- $15.74 – $25.09
- 50-day average
- $22.88
- 200-day average
- $19.67
Price action over the past year
In 209 trading sessions since December 23, 2025, TMO closed higher on 106 days (51%).
Its best day was July 23, 2026 (+9.04%) and its worst was April 23, 2026 (-9.47%).
It never moved 10% or more in a single session.
It opened at least 5% above the previous day's high 1 time.
Recent signals
TMO news
-
Oct 23, 2026:
Should Illumina Stock Holders Look At Thermo Fisher Instead?
-
Oct 23, 2026:
Thermo Fisher Scientific (TMO) Benefits on Broad-Based Recovery Across Life-Science Markets
-
Oct 23, 2026:
Clinical Laboratory Molecular Diagnostics for Infectious Diseases Market, 2025-2029: Forecast by Application, Place, and Country | Multiplex and Rapid Testing Unlock Growth
-
Oct 23, 2026:
NGS Kits Market Forecasts Growth from $6.84 Billion (2025) to $19.36 Billion by 2036, Profiling Illumina, Thermo Fisher Scientific, Roche, Oxford Nanopore & 11 Other Key Players
-
Oct 23, 2026:
Is Abbott Stock About To Rebound?
-
Oct 23, 2026:
Qiagen agrees to private equity takeover
-
Oct 23, 2026:
Here Are Friday's Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More
-
Oct 22, 2026:
Global Peptide Synthesis Market Forecast to 2031: Size, Share, Trends, and Growth | GLP-1 Boom Lifts Demand for Peptide Synthesis
About Thermo Fisher CDR (CAD Hedged)
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of more than $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.
Similar stocks
Find more stocks like TMO with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.